Brightspring Health Services, Stock Fundamentals
| BTSGU Stock | 69.71 0.29 0.41% |
BrightSpring Health Services, fundamentals help investors to digest information that contributes to BrightSpring Health's financial success or failures. It also enables traders to predict the movement of BrightSpring Stock. The fundamental analysis module provides a way to measure BrightSpring Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BrightSpring Health stock.
At this time, BrightSpring Health's Operating Income is comparatively stable compared to the past year. EBIT is likely to gain to about 231.7 M in 2025, whereas Depreciation And Amortization is likely to drop slightly above 216.4 M in 2025. BrightSpring | Select Account or Indicator |
BrightSpring Health Services, Company Revenue Analysis
BrightSpring Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current BrightSpring Health Revenue | 8.83 B |
Most of BrightSpring Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BrightSpring Health Services, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
BrightSpring Revenue Historical Pattern
Today, most investors in BrightSpring Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BrightSpring Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of BrightSpring Health revenue as a starting point in their analysis.
BrightSpring Health Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
BrightSpring Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, BrightSpring Health Services, reported 8.83 B of revenue. This is 15.73% higher than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The revenue for all United States stocks is 6.45% higher than that of the company.
BrightSpring Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BrightSpring Health's current stock value. Our valuation model uses many indicators to compare BrightSpring Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BrightSpring Health competition to find correlations between indicators driving BrightSpring Health's intrinsic value. More Info.BrightSpring Health Services, is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers . At this time, BrightSpring Health's Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value BrightSpring Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.BrightSpring Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BrightSpring Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BrightSpring Health could also be used in its relative valuation, which is a method of valuing BrightSpring Health by comparing valuation metrics of similar companies.BrightSpring Health is currently under evaluation in revenue category among its peers.
BrightSpring Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BrightSpring Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BrightSpring Health's managers, analysts, and investors.Environmental | Governance | Social |
BrightSpring Fundamentals
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.02) % | ||||
| Number Of Shares Shorted | 8.76 K | ||||
| Revenue | 8.83 B | ||||
| Gross Profit | 1.4 B | ||||
| EBITDA | 349.52 M | ||||
| Net Income | (154.6 M) | ||||
| Total Debt | 3.67 B | ||||
| Cash Flow From Operations | 210.78 M | ||||
| Number Of Employees | 35 K | ||||
| Total Asset | 5.53 B | ||||
| Retained Earnings | (200.32 M) | ||||
| Working Capital | 208.2 M | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 5.53 B |
About BrightSpring Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BrightSpring Health Services,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BrightSpring Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BrightSpring Health Services, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 35.5 M | 25.6 M | |
| Total Revenue | 10.2 B | 7.9 B | |
| Cost Of Revenue | 8.5 B | 6.5 B | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 59.29 | 56.33 | |
| Ebit Per Revenue | 0.02 | 0.04 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BrightSpring Stock Analysis
When running BrightSpring Health's price analysis, check to measure BrightSpring Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightSpring Health is operating at the current time. Most of BrightSpring Health's value examination focuses on studying past and present price action to predict the probability of BrightSpring Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightSpring Health's price. Additionally, you may evaluate how the addition of BrightSpring Health to your portfolios can decrease your overall portfolio volatility.